Bessemer Group Inc. Has $761,000 Position in Teleflex Incorporated (NYSE:TFX)

Bessemer Group Inc. trimmed its position in Teleflex Incorporated (NYSE:TFX - Free Report) by 76.7% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 5,511 shares of the medical technology company's stock after selling 18,147 shares during the period. Bessemer Group Inc.'s holdings in Teleflex were worth $761,000 as of its most recent SEC filing.

A number of other institutional investors have also recently added to or reduced their stakes in the company. IFP Advisors Inc raised its stake in shares of Teleflex by 238.5% in the 4th quarter. IFP Advisors Inc now owns 308 shares of the medical technology company's stock worth $55,000 after buying an additional 217 shares in the last quarter. Proficio Capital Partners LLC acquired a new position in Teleflex during the fourth quarter worth about $3,297,000. QRG Capital Management Inc. raised its position in Teleflex by 5.8% in the fourth quarter. QRG Capital Management Inc. now owns 2,178 shares of the medical technology company's stock worth $388,000 after acquiring an additional 119 shares in the last quarter. Mutual of America Capital Management LLC lifted its holdings in Teleflex by 117.7% in the 4th quarter. Mutual of America Capital Management LLC now owns 30,757 shares of the medical technology company's stock valued at $5,474,000 after acquiring an additional 16,629 shares during the last quarter. Finally, Kohmann Bosshard Financial Services LLC bought a new position in shares of Teleflex during the 4th quarter valued at about $73,000. 95.62% of the stock is currently owned by institutional investors and hedge funds.

Teleflex Trading Down 0.8%

NYSE TFX traded down $1.01 on Wednesday, hitting $120.82. 59,697 shares of the stock were exchanged, compared to its average volume of 627,833. The company's 50-day moving average price is $123.99 and its two-hundred day moving average price is $146.72. The company has a debt-to-equity ratio of 0.44, a current ratio of 2.28 and a quick ratio of 1.32. Teleflex Incorporated has a 52-week low of $115.94 and a 52-week high of $249.91. The company has a market capitalization of $5.34 billion, a price-to-earnings ratio of 38.02, a P/E/G ratio of 1.85 and a beta of 1.08.

Teleflex (NYSE:TFX - Get Free Report) last issued its quarterly earnings results on Thursday, May 1st. The medical technology company reported $2.91 earnings per share for the quarter, beating analysts' consensus estimates of $2.88 by $0.03. The business had revenue of $700.67 million for the quarter, compared to the consensus estimate of $699.37 million. Teleflex had a return on equity of 14.73% and a net margin of 4.96%. Teleflex's revenue for the quarter was down 5.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $3.21 earnings per share. Research analysts predict that Teleflex Incorporated will post 13.98 EPS for the current year.

Teleflex Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, June 16th. Stockholders of record on Tuesday, May 20th were issued a $0.34 dividend. The ex-dividend date of this dividend was Tuesday, May 20th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.13%. Teleflex's dividend payout ratio is 42.90%.

Wall Street Analyst Weigh In

TFX has been the topic of a number of research reports. Wells Fargo & Company dropped their target price on shares of Teleflex from $146.00 to $137.00 and set an "equal weight" rating on the stock in a report on Friday, May 2nd. Royal Bank Of Canada decreased their price target on shares of Teleflex from $150.00 to $145.00 and set a "sector perform" rating on the stock in a research report on Friday, May 2nd. Wall Street Zen downgraded Teleflex from a "buy" rating to a "hold" rating in a research report on Sunday. Bank of America lowered Teleflex from a "neutral" rating to an "underperform" rating and reduced their price objective for the stock from $235.00 to $140.00 in a research note on Tuesday, March 4th. Finally, Mizuho set a $155.00 target price on Teleflex in a research report on Wednesday, April 16th. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and two have assigned a buy rating to the company's stock. According to MarketBeat, the stock has an average rating of "Hold" and a consensus target price of $164.63.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.